Treatment Registry
TR-0639 ActiveRecorded September 2026

Oral semaglutide

Sold by NuuVim · Sublingual · every oral semaglutide record

Recorded initial charges

Initial payment · 3-month plan

$399

Monthly equivalent

$133

initial payment (3-month medication term), including required fees on record. The monthly equivalent is not a monthly bill. It combines the advertised medication rate with any recorded monthly membership and excludes one-time and annual fees. Renewal charges are not established by that figure. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Oral Semaglutide, standard/renewal rate · recorded upfront charge for 3 months$399

Added from the figures recorded below.

Price

TermPer monthCharged today
Oral Semaglutide, standard/renewal rate

“$133 / month $399 Total Standard rate · 3-month billing plan”

Per month$133Charged today$399
Price sources
Visit NuuVim

We earn nothing from this link. It opens NuuVim's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PharmacyHallandale Pharmacy, Fort Lauderdale FL; VialsRX, Houston TX
StatesAll 50 states
PrescriberAsynchronous review
CancellationSubscription Services automatically renew based on the billing cycle presented during checkout. You may cancel at any time through the patient portal or emailing: support@NuuVim.com .

Not yet checked: membership and consult fee.

Recorded from nuuvim.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — The Oral Tirzepatide SKU has no enum match (no 'oral tirzepatide' drug type exists on this register); recorded as compounded tirzepatide with form sublingual since the page tags it COMPOUNDED and describes it as a sublingual liposomal liquid, same as Oral Semaglutide.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0639
Medication category
oral semaglutide
Readings
1

Related records

Other records from NuuVim

All NuuVim programs and terms

Oral semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 58 records of the same molecule.

Cite this entry

Treatment Registry. (2026). NuuVim — oral semaglutide (TR-0639). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0639

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.